Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

31 Jul 2017 Evaluate

Alembic Pharmaceuticals has informed about press release titled ‘Alembic Pharmaceuticals receives USFDA Approval for Doxycycline Capsules USP, 75 mg and 100 mg’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..